The Cellular Energy Carrier

NAD+

Nicotinamide adenine dinucleotide — a coenzyme found in every living cell that ferries electrons through energy metabolism and fuels the enzymes behind DNA repair and cellular defense. Levels decline significantly with age.

Coenzyme, not a peptide Central to mitochondrial energy production Roughly halves from age 20 to 60
NAD+ mascot

What it is

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every living cell — not a peptide, but studied heavily alongside peptides in longevity and cellular-energy research. It's central to how cells convert food into usable energy, and it's required by many of the enzymes that keep cells' DNA and antioxidant defenses in working order.

How researchers think it works

NAD+ is best known as an electron carrier: in its reduced form (NADH), it delivers electrons to the first complex of the mitochondrial electron transport chain, the process that generates most of a cell's ATP. But NAD+ is also a required cofactor for enzymes that have nothing to do with energy production directly.

Illustrated diagram of NAD+ carrying electrons in redox reactions, supporting ATP production, and linking metabolism to cell signaling.
Conceptual overview. NAD+ is studied for its role in cellular energy metabolism and signaling — a simplified overview, not a clinical claim.

Carries electrons in redox reactions

As NAD+ cycles to NADH and back, it shuttles electrons through the reactions that break down food into usable energy — the core of cellular respiration.

Fuels sirtuins — DNA-repair and stress-defense enzymes

Sirtuins (SIRT1–5) are NAD+-dependent enzymes tied to DNA-damage defense, antioxidant pathways, and repair, and are studied for their association with healthy aging across multiple species. Without enough NAD+ on hand, sirtuin activity drops.

Fuels PARP — another DNA-repair pathway

Poly(ADP-ribose) polymerase (PARP) is a separate DNA-repair enzyme that also depends on NAD+. Repairing DNA damage consumes NAD+, so researchers note that heavy or ongoing DNA damage can deplete the pool available for other NAD+-dependent jobs.

What researchers look at

Most human-facing research uses NAD+ precursors (such as NR or NMN) or IV administration rather than NAD+ itself, since direct cellular uptake of NAD+ is limited.

What the evidence does not show. The age-related decline in NAD+ is well documented, and the sirtuin/PARP biology is well studied in cells and animals. But NAD+ (and its precursors) are not FDA-approved for anti-aging, energy, or performance use in people, and human outcome data is still limited. Nothing on this page is a recommendation to use it, and no dose is given or implied.

Keep exploring

Peptide Curious provides educational and editorial content only. It is not medical advice and is not a substitute for a qualified healthcare professional. NAD+ is discussed here as a research compound; content may describe emerging research not approved for clinical use.